Cipla is trading at Rs 1439.05, reflecting a 2.73% decrease today, while the one-week returns are at 1.6%. Cipla is currently priced at Rs 1434.00, indicating a 3.07% drop for today. The five-day ...

At the awards night, Cipla took home a total of 4 metals across categories for its impressive work and creativity. The brand won 2 silver and 2 bronze metals across categories. Apart from Cipla ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

Cipla Ltd. has expressed optimism about exceeding its FY25 guidance, supported by strong operational performance and a focused strategy. The company stated that supply challenges related to Lanreotide ...

Cipla's shares are currently priced at Rs 1439.65, reflecting a modest rise of 0.82%. The 7-day simple moving average is Rs 1475.93. Cipla is currently valued at Rs 1437.65, with a daily increase of 0 ...

Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the manufacturing facility of Medispray Laboratories Private Limited, a wholly ...

Cipla said the United States Food and Drug Administration (USFDA) conducted an inspection at the manufacturing facility of its subsidiary, Medispray Laboratories, in Goa, from 14 to 20 January 2025.

Pharma major Cipla Ltd on Monday (January 20) announced that the United States Food and Drug Administration (FDA) conducted an inspection of its wholly-owned subsidiary, Medispray Laboratories Private ...

Drug major Cipla has been hit with a penalty of Rs 9.77 crore by the GST Authority for alleged tax violations under the Central Goods and Services Tax Act, 2017, and related regulations. The order, ...

Objective: To compare the efficacy and tolerability of a salmeterol/fluticasone propionate (FP) combination product (50/100µg twice daily) with budesonide (BUD) at a four-fold higher microgram ...